{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:13:35Z","timestamp":1781198015822,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcmd.2026.102987","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:20:26Z","timestamp":1771460426000},"page":"102987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inflammatory markers in sickle cell disease during vaso-occlusive crisis"],"prefix":"10.1016","volume":"118","author":[{"given":"Kamal Kumar","family":"Meher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyabrata","family":"Meher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2026.102987_bb0005","series-title":"Wintrobe\u2019s Clinical Hematology, 14e","first-page":"823","article-title":"Sickle cell anemia and other sickling syndromes","author":"Hankins","year":"2019"},{"key":"10.1016\/j.bcmd.2026.102987_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2026.102987_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2026.102987_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.bcmd.2026.102987_bb0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/ijmr.IJMR_572_19","article-title":"Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises","volume":"156","author":"Soren","year":"2022","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bcmd.2026.102987_bb0030","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00277-019-03776-x","article-title":"Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India","volume":"98","author":"Meher","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2026.102987_bb0035","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102987_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102987_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice","volume":"106","author":"Kaul","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2026.102987_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.bcmd.2026.102987_bb0055","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.htct.2021.06.012","article-title":"Iron profile of pregnant sickle cell anemia patients in Odisha, India","volume":"45","author":"Sukla","year":"2023","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"10.1016\/j.bcmd.2026.102987_bb0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ajcp\/68.4.505","article-title":"Recommendation for measurement of erythrocyte sedimentation rate of human blood: International committee for standardization in haematology","volume":"68","author":"Von Boroviczeny","year":"1977","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2026.102987_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood-2020-140756","article-title":"Prevalence of vaso-occlusive crises in patients with sickle cell disease: a retrospective US claims database analysis","volume":"136","author":"Oladapo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102987_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management","volume":"105","author":"Darbari","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102987_bb0075","first-page":"72","article-title":"Correlation of serum C-reactive protein in painful vaso-occlusive crisis in sickle cell disease and its response to analgesic therapy","volume":"5","author":"Bijwe","year":"2018","journal-title":"IAIM"},{"key":"10.1016\/j.bcmd.2026.102987_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2026.102987_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bcmd.2010.08.003","article-title":"The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease","volume":"45","author":"Mohammed","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2026.102987_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155534","article-title":"Evaluation of the expression of red blood cell CD36, interleukin-6 and interleukin-8 in sickle cell anemia pediatric patients","volume":"143","author":"Abdul-Hussein","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.bcmd.2026.102987_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1684\/ecn.2013.0328","article-title":"Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition","volume":"24","author":"Keikhaei","year":"2013","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcmd.2026.102987_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/jcp.39.3.253","article-title":"Serum ferritin concentration in sickle cell crisis","volume":"39","author":"Brownell","year":"1986","journal-title":"J. Clin. Pathol."},{"issue":"e70773","key":"10.1016\/j.bcmd.2026.102987_bb0105","first-page":"1","article-title":"Inflammation and Iron profile in children with sickle cell disease in Cameroon: frequency and associated factors, an analytical cross-sectional study","volume":"8","author":"Tuono","year":"2025","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.bcmd.2026.102987_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1537-2995.2006.00679.x","article-title":"Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia","volume":"46","author":"Ballas","year":"2006","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.bcmd.2026.102987_bb0115","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.14260\/jemds\/2019\/676","article-title":"Clinical profile of patients of sickle cell crisis in a rural tertiary care hospital","volume":"8","author":"Verghese","year":"2019","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"10.1016\/j.bcmd.2026.102987_bb0120","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.htct.2020.07.011","article-title":"Effects of hydroxyurea on cytotoxicity, inflammation and oxidative stress markers in neutrophils of patients with sickle cell anemia: dose-effect relationship","volume":"43","author":"Pedrosa","year":"2021","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"10.1016\/j.bcmd.2026.102987_bb0125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3324\/haematol.2011.041988","article-title":"The rationale for using hydroxycarbamide in the treatment of sickle cell disease","volume":"96","author":"Rees","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2026.102987_bb0130","first-page":"1","article-title":"Association of G\u03b3-158C>T XmnI polymorphism with elevated HbF percentage in Sickle Cell Anemia patients: evidence from a case-control study and meta-analysis","volume":"46","author":"Meher","year":"2025","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bcmd.2026.102987_bb0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005792-199611000-00002","article-title":"Hydroxyurea and sickle cell anemia clinical utility of a myelosuppressive \u201cswitching\u201d agent","volume":"75","author":"Charache","year":"1996","journal-title":"Medicine"},{"key":"10.1016\/j.bcmd.2026.102987_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2009.1.62","article-title":"Advances in the use of hydroxyurea","volume":"2009","author":"Ware","year":"2009","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2026.102987_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619895111","article-title":"Effect of hydroxyurea treatment on the inflammatory markers among children with sickle cell disease","volume":"26","author":"Zahran","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2026.102987_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2026.102987_bb0155","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood.V112.11.2490.2490","article-title":"Production and expression of inflammatory mediators in leukocytes of sickle cell Anaemia patients and effects of hydroxyurea therapy on this production","volume":"112","author":"Lanaro","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102987_bb0160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5581\/1516-8484.20110055","article-title":"Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Cear\u00e1, Brazil","volume":"33","author":"Neto","year":"2011","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.bcmd.2026.102987_bb0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ebiom.2016.06.038","article-title":"Score predicting acute chest syndrome during vaso-occlusive crises in adult sickle-cell disease patients","volume":"10","author":"Bartolucci","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcmd.2026.102987_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2014.11.030","article-title":"Serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition","volume":"72","author":"Sarray","year":"2015","journal-title":"Cytokine"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:19:08Z","timestamp":1772849948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979626000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"alternative-id":["S1079979626000100"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.102987","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory markers in sickle cell disease during vaso-occlusive crisis","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.102987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102987"}}